Achilles Therapeutics plc financial data

Location
London, United Kingdom
Fiscal year end
31 December
Latest financial report
6-K - Q2 2024 - 14 Aug 2024

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 41,087,901 shares 0.35%
Common Stock, Value, Issued $54,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 40,355,972 shares 1.1%
Weighted Average Number of Shares Outstanding, Diluted 40,355,972 shares 1.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $13,635,000 USD -1%
General and Administrative Expense $4,164,000 USD -3.6%
Operating Income (Loss) $17,799,000 USD 1.6%
Nonoperating Income (Expense) $1,427,000 USD 18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $16,372,000 USD 3%
Income Tax Expense (Benefit) $8,000 USD
Net Income (Loss) Attributable to Parent $16,380,000 USD 2.8%
Earnings Per Share, Basic -0.41 USD/shares 2.4%
Earnings Per Share, Diluted -0.41 USD/shares 2.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $95,111,000 USD -34%
Other Assets, Current $2,126,000 USD -40%
Assets, Current $117,817,000 USD -33%
Deferred Income Tax Assets, Net $41,000 USD -78%
Property, Plant and Equipment, Net $6,954,000 USD -36%
Operating Lease, Right-of-Use Asset $4,165,000 USD -50%
Other Assets, Noncurrent $2,156,000 USD -32%
Assets $131,186,000 USD -34%
Accounts Payable, Current $2,865,000 USD -58%
Employee-related Liabilities, Current $2,109,000 USD -12%
Accrued Liabilities, Current $7,225,000 USD -4.5%
Liabilities, Current $14,295,000 USD -25%
Operating Lease, Liability, Noncurrent $258,000 USD -94%
Other Liabilities, Noncurrent $1,158,000 USD 19%
Liabilities $15,711,000 USD -35%
Accumulated Other Comprehensive Income (Loss), Net of Tax $14,015,000 USD -0.82%
Retained Earnings (Accumulated Deficit) $288,606,000 USD -28%
Stockholders' Equity Attributable to Parent $115,475,000 USD -34%
Liabilities and Equity $131,186,000 USD -34%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 41,087,901 shares 0.35%
Common Stock, Shares, Issued 41,087,901 shares 0.35%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95,164,000 USD -34%
Operating Lease, Liability $4,463,000 USD -48%
Depreciation $1,200,000 USD -7.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $16,185,000 USD -24%
Lessee, Operating Lease, Liability, to be Paid $4,660,000 USD -49%
Property, Plant and Equipment, Gross $22,093,000 USD 2.5%
Operating Lease, Liability, Current $4,205,000 USD -9.7%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,437,000 USD -49%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $197,000 USD -61%
Additional Paid in Capital $417,914,000 USD 1.4%
Share-based Payment Arrangement, Expense $1,312,000 USD -23%